£17.05
+ £0.32 (1.91%)
End-of-day quote: 05/01/2024
LSE:GSK

GSK Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
£30.33B £29.32B £24.70B £34.10B £33.75B £30.82B £30.19B £27.89B £23.92B £23.01B £26.51B £26.43B £27.39B £28.39B £28.37B £24.35B £22.72B £23.23B £21.66B £19.99B
GM % Gross Margin %
72.34% 67.92% 67.47% 68.06% 68.03% 68.48% 69.13% 68.06% 62.99% 68.17% 67.52% 69.54% 71.98% 72.88% 74.95% 76.28% 77.08% 78.43% 78.01% 78.18%
OM Operating Margin
27.71% 24.97% 22.81% 24.74% 24.30% 24.32% 22.27% 18.96% 10.65% 17.36% 22.12% 22.52% 27.31% 32.01% 32.07% 35.48% 34.06% 34.39% 32.54% 28.10%
EPS Earnings Per Share
£0.00 £1.55 £1.40 £1.42 £1.45 £1.55 £1.49 £1.40 £1.28 £0.94 £1.19 £1.38 £1.39 £1.41 £0.67 £1.50 £1.30 £1.23 £1.18 £1.03 £0.94
Div. Dividends
£0.58 £0.61 £1.00 £1.00 £1.00 £1.00 £1.00 £1.00 £1.25 £1.00 £0.98 £0.93 £0.88 £0.81 £0.76 £0.71 £0.66 £0.60 £0.55 £0.53
PR % Payout Ratio %
37.42% 43.57% 70.42% 68.97% 64.52% 67.11% 71.43% 78.13% 132.98% 84.03% 71.01% 66.91% 62.41% 120.90% 50.67% 54.62% 53.66% 50.85% 53.40% 56.38%
Sha. Shares
4056.26m 4034.34m 4006.88m 3984.81m 3962.58m 3938.34m 3,913m 3893.69m 3871.85m 3848.96m 3832.95m 3862.08m 3966.4m 4073.01m 4058.35m 4046.5m 4299.09m 4482.13m 4522.11m 4554.57m
OCF Operating Cash Flow
£6.77B £7.40B £7.95B £8.44B £8.02B £8.42B £6.92B £6.50B £2.57B £5.18B £7.22B £4.38B £6.25B £6.80B £7.84B £7.21B £6.16B £4.36B £5.96B £4.94B
FCF Free Cash Flow
£5.61B £6.26B £4.44B £5.41B £5.07B £5.69B £5.37B £4.95B £1.19B £3.99B £6.03B £3.32B £5.33B £5.72B £6.42B £5.77B £4.65B £2.99B £5.05B £4.16B
FCFS Free Cash Flow Per Share
£1.09 £1.33 £1.48 £1.87 £1.58 £1.75 £1.22 £1.14 £0.23 £0.98 £1.46 £1.00 £1.28 £1.30 £1.56 £1.28 £0.91 £0.65 £1.10 £0.85